Science News

An expert reveals what recent clinical trials have taught us, and why a one-size-fits-all approach won’t work.

Ruchira Singh and colleagues at the University of Rochester and worldwide have shown that even rare forms of macular degeneration develop in ways similar to AMD, with drusen formation and extracellular proteins. The goal ahead: effective early treatment approaches.

Using atomic-level imaging, Paul Seidler, UCLA, looks at how tau protein creates tangles in Alzheimer’s—and how to stop it with well-designed drugs. The work is supported by a partnership between BrightFocus and Alzheimer’s Los Angeles. .